IMPACT-HTN Study of Patients With Hypertension (NCT07579260)
Prospective Early Patient Experience Initiative (IMPACT-HTN)
🩺 Plain-English Summary (8th-Grade Level)
An estimated 120 million people have high blood pressure (hypertension) in the US, of which approximately 10% have resistant hypertension. This study aims to enroll patients who continue to have hypertension while being treated with at least two medications. The study will follow patients for approximately 3 months and collect real-world information on changes in their health to identify an ideal patient profile that would benefit from 4th-line antihypertensive therapies, including, but not limited to, FDA-approved aprocitentan, renal denervation, mineralocorticoid receptor antagonists, etc.
Who can join: Review the eligibility criteria below.
Location: Stanford University Hypertension Center — Palo Alto, California
Age range: 18 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Stanford University Hypertension Center — Palo Alto, California
- Duke University Hospital — Durham, North Carolina
📞 Contact the Study Coordinator
Phone: (650) 947-7025
Email: nicholus@stanford.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Hypertension (HTN)
- Mediterranean-DASH Intervention for Neurodegenerative Delay and High-Intensity Interval Training in Adults With Hypertension — Houston, Texas
- The BASIC-S Feasibility Study for Vascular Risk Reduction — London, Ontario
- Dual-Language B-MORE for Hypertension — Orlando, Florida
- Assessing the Feasibility of the "Heart Care Pairs" Intervention — Birmingham, Alabama
- Genetic Architecture of Natriuretic Peptides and Blood Pressure Response — Birmingham, Alabama
Explore by condition: All Hypertension (HTN) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.